Immunology, Cell biology, T cell, Antigen and Immune system are his primary areas of study. His Cell biology study combines topics from a wide range of disciplines, such as Receptor, IL-2 receptor and CD80. Koji Tamada has included themes like Cytokine, Immune tolerance, Cancer immunotherapy, Molecular biology and Cytotoxic T cell in his T cell study.
Within one scientific family, Koji Tamada focuses on topics pertaining to Tumor necrosis factor alpha under Cancer immunotherapy, and may sometimes address concerns connected to Cancer research. His work in Antigen covers topics such as B7-H1 Antigen which are related to areas like Blockade. His Immune system research is multidisciplinary, incorporating elements of Interleukin 12 and Infiltration.
His main research concerns Immunology, Cancer research, Immune system, T cell and Cytotoxic T cell. Koji Tamada focuses mostly in the field of Immunology, narrowing it down to matters related to Interleukin 12 and, in some cases, CD40. His Cancer research course of study focuses on Tumor necrosis factor alpha and Signal transduction.
His studies in T cell integrate themes in fields like Molecular biology, CD80, Immune tolerance and Cell biology. Transplantation is closely connected to T lymphocyte in his research, which is encompassed under the umbrella topic of Cytotoxic T cell. His Antigen research integrates issues from Tumor microenvironment, B7-H1 Antigen and Clonal anergy.
Koji Tamada mostly deals with Cancer research, Antigen, Antibody, Immune system and Cancer immunotherapy. His research in Cancer research intersects with topics in Chemokine, Chimeric antigen receptor, Immunotherapy and Cell therapy. He specializes in Antigen, namely Peptide vaccine.
T cell and CD8 are the core of his Immune system study. His T cell research includes elements of Cytotoxic T cell and Dendritic cell. Koji Tamada has researched Cancer immunotherapy in several fields, including Vector, Blockade, Clinical trial and Virology.
The scientist’s investigation covers issues in Cancer research, Chimeric antigen receptor, Immunotherapy, Antigen and Tumor microenvironment. His studies deal with areas such as Immunohistochemistry, Peptide vaccine, Human leukocyte antigen, XCL1 and Programmed cell death as well as Cancer research. His Human leukocyte antigen study integrates concerns from other disciplines, such as Glypican 3, Immune system, Poly ICLC, Antibody and TIGIT.
He is involved in the study of Immune system that focuses on T cell in particular. His biological study spans a wide range of topics, including Induced pluripotent stem cell, Innate lymphoid cell, Interferon gamma and Cancer immunotherapy. His Tumor microenvironment study combines topics in areas such as Haematopoiesis, Ligand, Downregulation and upregulation, Immunity and PD-L1.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
Haidong Dong;Scott E. Strome;Diva R. Salomao;Hideto Tamura.
Nature Medicine (2002)
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
Haidong Dong;Gefeng Zhu;Koji Tamada;Lieping Chen.
Nature Medicine (1999)
Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity
Fumiya Hirano;Katsumi Kaneko;Hideto Tamura;Haidong Dong.
Cancer Research (2005)
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
Andrei I. Chapoval;Jian Ni;Julie S. Lau;Ryan A. Wilcox.
Nature Immunology (2001)
B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.
Gabriel L. Sica;In Hak Choi;In Hak Choi;Gefeng Zhu;Koji Tamada.
B7-H1 Blockade Augments Adoptive T-Cell Immunotherapy for Squamous Cell Carcinoma
Scott E. Strome;Haidong Dong;Hideto Tamura;Stephen G. Voss.
Cancer Research (2003)
LIGHT, a TNF-Like Molecule, Costimulates T Cell Proliferation and Is Required for Dendritic Cell-Mediated Allogeneic T Cell Response
Koji Tamada;Koji Shimozaki;Andrei I. Chapoval;Yifan Zhai.
Journal of Immunology (2000)
B7-H1 Determines Accumulation and Deletion of Intrahepatic CD8+ T Lymphocytes
Haidong Dong;Gefeng Zhu;Koji Tamada;Dallas B. Flies.
Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS
Shengdian Wang;Gefeng Zhu;Andrei I. Chapoval;Haidong Dong.
Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway
Koji Tamada;Koji Shimozaki;Andrei I. Chapoval;Gefeng Zhu.
Nature Medicine (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: